Abiopharma

Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call

Mentorship Matters: How to Build a STEM Network That Lifts You Up

Corkrean John J 🟢 acquired 275.4K shares (13 derivative) of FULLER H B CO (FUL) at $77.72 ($15.2M) Transaction Date: Jan 16, 2026 | Filing ID: 000666

Campe Heather 🟢 acquired 88.1K shares (10 derivative) of FULLER H B CO (FUL) at $77.72 ($5.2M) Transaction Date: Jan 16, 2026 | Filing ID: 000665

Shareholder Alert: The Ademi Firm investigates whether RAPT Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders

Kick off 2026 with CAHPS Insider Live

Director Grace Caroline 🟡 adjusted position in 119.5K shares (4 derivative) of AMN HEALTHCARE SERVICES INC (AMN) at $19.55 Transaction Date: Jan 15, 2026 | Filing ID: 002540

Tiziana Life Sciences Ltd. (TLSA) Files Form 6-K

New Form SCHEDULE 13G/A - MAINZ BIOMED N.V. Filed: 2026-01-20 AccNo: 0002105585-26-000006 Size: 5 KB

(99% Neutral) Hillstream BioPharma Inc. (was rebranding to Tharimmune Inc (THAR)) (HILS) Announces Business Combination

New Form DEF 14A - Healthcare Triangle, Inc. Filed: 2026-01-20 AccNo: 0001213900-26-005400 Size: 1 MB

New Form 4/A - MAINZ BIOMED N.V. Filed: 2026-01-20 AccNo: 0002105585-26-000005 Size: 4 KB

New Form 3/A - MAINZ BIOMED N.V. Filed: 2026-01-20 AccNo: 0002105585-26-000004 Size: 3 KB

MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum

New Form SCHEDULE 13G/A - Apyx Medical Corp Filed: 2026-01-20 AccNo: 0000906304-26-000004 Size: 10 KB